相关实验视频
Updated: Jan 17, 2026

03:20
Studying Chronic Exposure of Mice to Ultraviolet B Radiation
Published on: August 19, 2025
1.9K
免疫检查点抑制剂诱导的白风:一个大规模的现实世界药监测研究
Bufu Tang1, Yanming Yu2, Juncheng Wan1
1Department of Interventional Radiology, Zhongshan Hospital, Shanghai Institute of Medical Imaging, National Clinical Research Center of Interventional Medicine, Fudan University, Shanghai, China.
International journal of cancer
|September 18, 2025
概括
免疫检查点抑制剂 (ICI) 可以导致白风,这是一个具有预后价值的免疫相关不良事件 (irAE). 这项研究发现白风与黑色素瘤以外的各种癌症有关,影响了免疫治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药物监督 药物监督 药物监督
背景情况:
- 免疫检查点抑制剂 (ICI) 已经改变了癌症治疗.
- 与免疫相关的不良事件 (irAEs) 在ICI中很常见.
- 风是一种irAE,在癌症患者中显示出新兴的预后意义.
研究的目的:
- 调查与ICI相关的白风的流行病学和临床特征.
- 为了确定白风和ICI治疗的各种癌症类型之间的关联.
- 探索接受免疫治疗的患者白风的预后价值.
主要方法:
- 使用FAERS数据库 (2015Q1-2024Q3) 进行大规模药监测分析.
- 不成比例分析 (报告几率比 - ROR) 按ICI类,癌症类型和患者特征分层.
- 通用添加模型 (GAM) 分析,以评估白风和临床因素之间的关系.
主要成果:
- 在162,022个报告的ICI相关不良事件中,发现了359例白风 (0.22%).
- 常见的相关恶性瘤包括黑色素瘤 (59.4%),转移性恶性瘤 (28%) 和肺癌 (6.8%).
- 鉴定了白风和黑色素瘤以外的恶性瘤之间的新相关性;证实了白风和风险/时间发展之间的非线性关系.
结论:
- Vitiligo 是一个重要的 irAE,在多种癌症类型中具有预后价值.
- 这些发现支持白风作为优化风险分层和个性化免疫治疗的生物标志物.
- 代谢因素可能会调节ICI相关的白风的临床表现.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Bioequivalence studies: Biowaivers
229
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
229
Therapeutic Drug Monitoring: Affecting Factors
202
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
202
Changes in Skin Color: Clinical Perspectives
3.3K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.3K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
493
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
493

